Home - Privacy Policy - Terms of Use - Site Map - Contact Us

NC-IUPHAR

Introduction

Receptor Database

Ion Channels
Compendium

Published articles


NC-IUPHAR: Published Articles

Last updated 10 October 2007


All links outside IUPHAR will open in a new window.

"Nature Reviews Drug Discovery"

Fredholm, B. B., Fleming, W. W., Vanhoutte, P. M. and Godfraind, T. (2002). The role of pharmacology in drug discovery. Nature Rev. Drug Discov., 1, 237-248.


"Pharmacological Reviews"

IUPHAR has a longstanding, formal collaboration with "Pharmacological Reviews". The official reports from the IUPHAR Committee on Receptor Nomenclature and Drug Classification are published in the journal. The 1994 publications appeared as a special issue to coincide with the XIIIth International Congress of Pharmacology in Munich, Germany. The 2002 publications appeared as a special issue to celebrate 10 years of the publishing collaboration between IUPHAR and ASPET. A complimentary copy was given to each delegate at the XIVth World Congress of Pharmacology in San Francisco, USA. Single copies of these issues and reprint packages can be purchased by contacting ASPET.

1992 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

Kenakin, T. P., Bond, R. A. and Bonner, T. I. (1992). International Union of Pharmacology. II. Definition of pharmacological receptors. Pharmacol. Rev., 44, 351-362.

Spedding, M. and Paoletti, R. (1992). International Union of Pharmacology. III. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol. Rev., 44, 363-376.

Vanhoutte, P. M., Barnard, E. A., Cosmides, G. J., Humphrey, P. P. A., Spedding, M. and Godfraind, T. (1994). International Union of Pharmacology. I. Committee on Receptor Nomenclature and Drug Cassification. Pharmacol. Rev., 46, 111-116.

Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R. Jr. and Trendelenburg, U. (1994). IV. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev., 46, 121-136.

Masaki T., Vane, J. R. and Vanhoutte, P. M. (1994). V. International Union of Pharmacology Nomenclature of endothelin receptors. Pharmacol. Rev., 46, 137-142.

Fredholm B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P. and Williams, M. (1994). VI. Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.

Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R. and Humphrey, P. P. A. (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytrytamine (Serotonin). Pharmacol. Rev., 46, 157-203.

Coleman, R. A., Smith, W. L. and Narumiya, S. (1994). VIII. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev., 46, 205-229.

Jenkinson, D. H., Barnard, E. A., Hoyer, D., Humphrey, P. P. A., Leff, P. and Shankley, N. P. (1995). International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. rev. 47, 255-265.

Hieble, J. P., Bylund, D. B., Clarke, D. E., Eikenburg D. C., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P. and Ruffolo, R. R. Jr. (1995). X. International Union of Pharmacology. Recommendation for nomenclature of α1-adrenoceptors: consensus update. Pharmacol. Rev., 47, 267-270.

Vanhoutte, P. M., Humphrey, P. P. A. and Spedding, M. (1996). International Union of Pharmacology. XI. Recommendations for nomenclature of new receptor subtypes. Pharmacol. Rev., 48, 1-2.

Dhawan, B. N., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P. B., Portoghese, P. S. and Hamon, M. (1996). International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., strong>48,567-592.

Hill, S. J., Ganellin, C. R., Timmerman, H., Schwartz, J-C., Shankley, N. P., Young, J. M., Schunack, W., Levi, R. and Haas, H. L. (1997). International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. rev. 49, 253-278.

Moncada, S., Higgs, A. and Furchgott, R. (1997). International Union of Pharmacology. XIV. Nomenclature in nitric oxide research. Pharmacol. Rev., 49, 137-142.

Barnard, E., A., Skolnick, P., Olsen, R. W., Mohler, H., Sieghart, W., Biggio, G., Braestrup, C., Bateson, A. N. and Langer, S. Z. (1998). International Union of Pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors. Classification on the basis of subunit structure and receptor function. Pharmacol. Rev.,50, 291-313.

Michel, M. C., Beck-Sickinger, A., Cox, H., Doods, H. N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T., Wahlestedt, C. and Westfall, T. (1998). International Union of Pharmacology. XVI. Recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.

Caulfield, M. P. and Birdsall, N. J. M. (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev., 50, 279-290.

Harmar, A. J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S. P., Wank, S. A. and Waschek, J. A. (1998). International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev., 50, 265-269.

Humphrey, P. P. A. and Barnard, E. A. (1998). International Union of Pharmacology. XIX. The IUPHAR Receptor Code: A proposal for an alphanumeric classification system. Pharmacol. Rev., 50, 271-277.

Lukas R. J., Changeux J. P., Le Novere, N., Albuquerque, E. X., Balfour, D. J. K., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B. S., Collins, A. C., Dani, J. A., Grady, S. R., Kellar, K. J., Lindstrom, J. M., Marks, M. J., Quik, M., Taylor, P. W. and Wonnacott, S. (1999). International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev., 51, 397-401.

Noble, F., Wank, S. A., Crawley, J. N., Bradwejn, J., Seroogy, K. B., Hamon, M. and Roques, B. P. (1999). International Union of Pharmacology. XXI. Structure, distribution and functions of cholecystokinin receptors. Pharmacol. Rev., 51, 745-781.

Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J. and Power, C. A. (2000). International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev., 52, 145-176.

de Gasparo, M., Catt, K.J., Inagami, T., Wright., J.W. and Unger, T. (2000). International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev., 52, 415-472.

Khakh, B. S., Burnstock, G., Kennedy, C., King, B. F., North R. A., éguéla, P., Voigt, M. and Humphrey, P. P. A. (2001). International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev., 53, 107-118.

Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K-A. and Linden, J. (2001). International Union of Pharmacology. XXV. Nomencalture and classification of adenosine receptors. Pharmacol. Rev., 53, 527-552.

Abernathy, D.R. and Ruffolo, R.R. Jr. (2002). International Union of Pharmacology. XXVI. Nomenclature and Pharmacological Reviews. Pharmacol. Rev., 54, 159.

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R. and Pertwee, R. G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.

Hollenberg, M. D. and Compton, S. J. (2002). International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol. Rev., 54, 203-218.

Davenport, A. P. (2002). International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol. Rev., 54, 219-226.

Murphy, P. M. (2002). International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev., 54, 227-230.

Spedding, M., Bonner, T. I. and Watson, S. P. (2002). International Union of Pharmacology. XXXI. Recommendations for the nomenclature of multimeric, G protein-coupled receptors. Pharmacol. Rev., 54, 231-232.

Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A. and Foord, S. M. (2002). International Union of Pharmacology. XXXII. The mammalian CGRP, adrenomedullin, amylin and calcitonin receptors. Pharmacol. Rev., 54: 233-246.

Bowery, N. G., Bettler, B., Froestl, W., Gallagher, J. P., Marshall, F., Raiteri, M., Bonner, T. I. and Enna, S. J. (2002). International Union of Pharmacology. XXXIII. Mammalian GABAB receptors: Structure and function. Pharmacol. Rev., 54: 247-264.

Chun, J., Goetzl, E. J., Hla, T. L., Igarashi, Y., Lynch, K. R., Moolenaar, W. H., Pyne, S. and Tigyi, G. (2002). International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev., 54: 265-270.

Richard L. Hauger, Dimitri E. Grigoriadis, Mary F. Dallman, Paul M. Plotsky, Wylie W. Vale, and Frank M. Dautzenberg. International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their LigandsPharmacol Rev. 2003 55: 21-26.

Kelly E. Mayo, Laurence J. Miller, Dominique Bataille, Stéphane Dalle, Burkhard Göke, Bernard Thorens, and Daniel J. Drucker. International Union of Pharmacology. XXXV. The Glucagon Receptor Family. Pharmacol Rev. 2003 55: 167-194.

Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, Simonetta Nicosia, Charles N. Serhan, Takao Shimizu, and Takehiko Yokomizo. International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacol Rev. 2003 55: 195-227.

William A. Catterall, K. G. Chandy, D. E. Clapham, G. A. Gutman, F. Hofmann, A. J. Harmar, D. R. Abernethy, and M. Spedding. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels. Pharmacol Rev 2003 55: 573-574.

William A. Catterall, Alan L. Goldin, and Stephen G. Waxman. International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels. Pharmacol Rev 2003 55: 575-578.

William A. Catterall, Joerg Striessnig, Terrance P. Snutch, and Edward Perez-Reyes. International Union of Pharmacology. XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels. Pharmacol Rev 2003 55: 579-581.

George A. Gutman, K. George Chandy, John P. Adelman, Jayashree Aiyar, Douglas A. Bayliss, David E. Clapham, Manuel Covarriubias, Gary V. Desir, Kiyoshi Furuichi, Barry Ganetzky, Maria L. Garcia, Stephan Grissmer, Lily Y. Jan, Andreas Karschin, Donghee Kim, Sabina Kuperschmidt, Yoshihisa Kurachi, Michel Lazdunski, Florian Lesage, Henry A. Lester, David McKinnon, Colin G. Nichols, Ita O'Kelly, Jonathan Robbins, Gail A. Robertson, Bernardo Rudy, Michael Sanguinetti, Susumu Seino, Walter Stuehmer, Michael M. Tamkun, Carol A. Vandenberg, Aguan Wei, Heike Wulff, and Randy S. Wymore. International Union of Pharmacology. XLI. Compendium of Voltage-Gated Ion Channels: Potassium Channels. Pharmacol Rev 2003 55: 583-586.

Franz Hofmann, Martin Biel, and U. Benjamin Kaupp International Union of Pharmacology. XLII. Compendium of Voltage-Gated Ion Channels: Cyclic Nucleotide-Modulated Channels. Pharmacol Rev 2003 55: 587-589.

David E. Clapham, Craig Montell, Guenter Schultz, and David Julius. International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels. Pharmacol Rev 2003 55: 591-596.

Richard R. Neubig, Michael Spedding, Terry Kenakin, and Arthur Christopoulos. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology.Pharmacol Rev 2003 55: 597-606.

Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu, and Takehiko Yokomizo International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor. Pharmacol Rev 2004 56: 149-157.

L. M. Fredrik Leeb-Lundberg, Francois Marceau, Werner Müller-Esterl, Douglas J. Pettibone, and Bruce L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences. Pharmacol Rev. 2005 57: 27-77.

Steven M. Foord, Tom I. Bonner, Richard R. Neubig, Edward M. Rosser, Jean-Phillipe Pin, Anthony P. Davenport, Michael Spedding, And Anthony J. Harmar International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List. Pharmacol Rev. 2005 Jun; 57(2):279-88.

Introduction to the IUPHAR Compendium of Voltage-Gated Ion Channels 2005Pharmacol Rev 2005 57: 385.

Frank H. Yu, Vladimir Yarov-Yarovoy, George A. Gutman, and William A. Catterall. Overview of Molecular Relationships in the Voltage-Gated Ion Channel Superfamily. Pharmacol Rev 2005 57: 387-395.

William A. Catterall, Alan L. Goldin, and Stephen G. Waxman. International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels. Pharmacol Rev 2005 57: 397-409.

William A. Catterall, Edward Perez-Reyes, Terrance P. Snutch, and Joerg Striessnig. International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels. Pharmacol Rev 2005 57: 411-425.

David E. Clapham, David Julius, Craig Montell, and Günter Schultz. International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels. Pharmacol Rev 2005 57: 427-450.

David E. Clapham and David L. Garbers. International Union of Pharmacology. L. Nomenclature and Structure-Function Relationships of CatSper and Two-Pore Channels. Pharmacol Rev 2005 57: 451-454.

Franz Hofmann, Martin Biel, and U. Benjamin Kaupp. International Union of Pharmacology. LI. Nomenclature and Structure-Function Relationships of Cyclic Nucleotide-Regulated Channels. Pharmacol Rev 2005 57: 455-462.

Aguan D. Wei, George A. Gutman, Richard Aldrich, K. George Chandy, Stephan Grissmer, and Heike Wulff. International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels. Pharmacol Rev 2005 57: 463-472.

George A. Gutman, K. George Chandy, Stephan Grissmer, Michel Lazdunski, David Mckinnon, Luis A. Pardo, Gail A. Robertson, Bernardo Rudy, Michael C. Sanguinetti, Walter Stühmer, and Xiaoliang Wang. International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels. Pharmacol Rev 2005 57: 473-508.

Yoshihiro Kubo, John P. Adelman, David E. Clapham, Lily Y. Jan, Andreas Karschin, Yoshihisa Kurachi, Michel Lazdunski, Colin G. Nichols, Susumu Seino, and Carol A. Vandenberg. International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels. Pharmacol Rev 2005 57: 509-526.

Steve A. N. Goldstein, Douglas A. Bayliss, Donghee Kim, Florian Lesage, Leigh Daniel Plant, and Sindhu Rajan. International Union of Pharmacology. LV. Nomenclature and Molecular Relationships of Two-P Potassium Channels. Pharmacol Rev 2005 57: 527-540.

Anthony P. Davenport, Tom I. Bonner, Steven M. Foord, Anthony J. Harmar, Richard R. Neubig, Jean-Philippe Pin, Michael Spedding, Masayasu Kojima, and Keniji Kangawa. International Union of Pharmacology. LVI. Ghrelin Receptor Nomenclature, Distribution, and Function. Pharmacol Rev 2005 57: 541-546.

Ross A. Bathgate, Richard Ivell, Barbara M. Sanborn, O. David Sherwood, and Roger J. Summers. International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol Rev 2006 58: 7-31.

Vincent Laudet and Michael Spedding, Foreword. Pharmacol Rev 2006 58: 684.

Pierre Germain, Bart Staels, Catherine Dacquet, Michael Spedding, and Vincent Laudet, Overview of Nomenclature of Nuclear Receptors
Pharmacol Rev 2006 58: 685-704.

Frédéric Flamant, John D. Baxter, Douglas Forrest, Samuel Refetoff, Herbert Samuels, Tom S. Scanlan, Bjorn Vennström, and Jacques Samarut, International Union of Pharmacology. LIX. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Thyroid Hormone Receptors
Pharmacol Rev 2006 58: 705-711.

Pierre Germain, Pierre Chambon, Gregor Eichele, Ronald M. Evans, Mitchell A. Lazar, Mark Leid, Angel R. De Lera, Reuben Lotan, David J. Mangelsdorf, and Hinrich Gronemeyer, International Union of Pharmacology. LX. Retinoic Acid Receptors
Pharmacol Rev 2006 58: 712-725.

Liliane Michalik, Johan Auwerx, Joel P. Berger, V. Krishna Chatterjee, Christopher K. Glass, Frank J. Gonzalez, Paul A. Grimaldi, Takashi Kadowaki, Mitchell A. Lazar, Stephen O'Rahilly, Colin N. A. Palmer, Jorge Plutzky, Janardan K. Reddy, Bruce M. Spiegelman, Bart Staels, and Walter Wahli, International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Pharmacol Rev 2006 58: 726-741.

David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao, and Steven A. Kliewer, International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor
Pharmacol Rev 2006 58: 742-759.

Pierre Germain, Pierre Chambon, Gregor Eichele, Ronald M. Evans, Mitchell A. Lazar, Mark Leid, Angel R. De Lera, Reuben Lotan, David J. Mangelsdorf, and Hinrich Gronemeyer, International Union of Pharmacology. LXIII. Retinoid X Receptors
Pharmacol Rev 2006 58: 760-772.

Karin Dahlman-Wright, Vincent Cavailles, Suzanne A. Fuqua, V. Craig Jordan, John A. Katzenellenbogen, Kenneth S. Korach, Adriana Maggi, Masami Muramatsu, Malcolm G. Parker, and Jan-Åke Gustafsson, International Union of Pharmacology. LXIV. Estrogen Receptors
Pharmacol Rev 2006 58: 773-781.

Nick Z. Lu, Suzanne E. Wardell, Kerry L. Burnstein, Donald Defranco, Peter J. Fuller, Vincent Giguere, Richard B. Hochberg, Lorraine McKay, Jack-Michel Renoir, Nancy L. Weigel, Elizabeth M. Wilson, Donald P. McDonnell, and John A. Cidlowski, International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
Pharmacol Rev 2006 58: 782-797.

Gérard Benoit, Austin Cooney, Vincent Giguere, Holly Ingraham, Mitch Lazar, George Muscat, Thomas Perlmann, Jean-Paul Renaud, John Schwabe, Frances Sladek, Ming-Jer Tsai, and Vincent Laudet, International Union of Pharmacology. LXVI. Orphan Nuclear Receptors
Pharmacol Rev 2006 58: 798-836.

Jean-Philippe Pin, Richard Neubig, Michel Bouvier, Lakshmi Devi, Marta Filizola, Jonathan A. Javitch, Martin J. Lohse, Graeme Milligan, Krzysztof Palczewski, Marc Parmentier, and Michael Spedding, International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers Pharmacol Rev 2007;59 5-13

Additional articles

Michael Spedding, Steve M Foord, Franz Hofmann. Current status of drug receptor nomenclature: receptor closure? The role of NC- IUPHAR. Expert Opin Investig Drugs. 2004 May;13 (5):461-4.

 
All content © IUPHAR 2002-2008